Quantum Biopharma (QNTM) Net Equity Issued and Repurchased (2020 - 2026)

Quantum Biopharma (QNTM) posted Net Equity Issued and Repurchased of $5.4 million for Q1 2026, down 23.41% sequentially from $7.0 million in Q3 2024.

Quantum Biopharma (QNTM) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

Quantum Biopharma has reported Net Equity Issued and Repurchased for 4 years, with the latest figure at $5.4 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	49.20 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Quantum Biopharma	15.44 Mn	11.80 Mn	-	-

Download Data